Tuesday, September 22, 2020 8:59:18 PM
Most Covid19 in vitro research as well as human trials have been funded by their big pharmaceutical companies trying to resurrect antiviral drugs which have under performed or even failed for other indications. The Big pharmas have manipulated trials in progress to make their drugs results appear better than they actually are.
Brilacidin is only a few weeks away from human trials. The pre trial price run up could start at any time. Between now and the start of human trials.We are should to have the following announcements:
- Pre IND meeting
- Pre print peer review articles
- CRO contract
- IND approval
- CDMO contract
- Human trial location[s]
- Trial protocol
-
Then the trials themselves will be short as are all infectious disease trials. Brilacidin may show results soon after the first infusion. Testing will determine the reduction of the viral load, reduction of systemic symptoms, reduced viral shedding and soon reduction in complications and mortality. A trend in the testing may be reported in an interim report.
Below is an article regarding the measurements done when the antiviral, Tamiflu, is given for influenza and the testing to measure drug response to the virus. Brilacidin will have similar tests performed
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110250/
IMO only ...time is getting short to accumulate shares at these prices. Of course human clinical trials can be unpredictable, but Brilacidin's pre trial results should give IPIX of a chance at success.
GLTA,Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM